Zydus Cadila's COVID vaccine set to be included in national anti-coronavirus inoculation program

08 Nov 2021 Evaluate

Zydus Cadila's three-dose Covid vaccine ZyCoV-D is set to be included in the national anti-coronavirus inoculation program this month with the Centre placing a purchase order with the Ahmedabad-based firm for one crore doses.

The Union Health Ministry is learned to have given the go-ahead to initiate the preparatory work for the introduction of the indigenously developed world's first DNA-based Covid jab, which in all probability will be given to adults initially under the country's vaccination drive.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

Zydus Lifesciences Share Price

867.80 -16.20 (-1.83%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×